Biological Activity |
Tyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor with IC50s of 4, 20, 4, 2 nM for KDR, Flt-1, FGFR1 and PDGFRalpha, respectively. IC50 & Target: IC50: 4 nM (KDR), 20 nM (Flt-1), 4 nM (FGFR1), 2 nM (PDGFRalpha)[1] In Vitro: Tyrosine kinase-IN-1 is from reference (compound 8K)[1]. In Vivo: Tyrosine kinase-IN-1 shows a reasonable PK profile (AUC(0-?)=1.9, t1/2=4.6 h). It has a favorable oral bioavailability (F=63%) in rats[1]. |